ArticleThe Journal of clinical investigation2010

Abrogating Cbl-b in effector CD8(+) T cells improves the efficacy of adoptive therapy of leukemia in mice.

Ingunn M Stromnes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.